Prevalence of Steatotic Liver Disease Subtypes and Association With Metabolic Risk Factors in the Framingham Heart Study.

Authors :: Sun N
Prescott B
Ma J
Mohanty A
Long MT
Walker ME
Source :: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2024 Nov; Vol. 22 (11), pp. 2330-2333. Date of Electronic Publication: 2024 Jun 09.
Publication Year :: 2024
Abstract: Recent updates in nomenclature and diagnostic criteria encompass the diverse phenotypes associated with steatotic liver disease (SLD). <superscript>1</superscript> These updates aim to reflect the current understanding of SLD, promote disease awareness and research, and reduce stigma. Notably, the term metabolic dysfunction-associated steatotic liver disease (MASLD) is defined as hepatic steatosis with at least 1 of 5 cardiometabolic criteria without any other cause of steatosis. A new category, MetALD, includes those with MASLD and high alcohol intake. <superscript>1</superscript> We aimed to characterize SLD using this nomenclature in the Framingham Heart Study (FHS) and to quantify its association with cardiometabolic risk factors.<br /> (Copyright © 2024 AGA Institute. Published by Elsevier Inc. All rights reserved.)

Subjects :: Humans
Prevalence
Male
Middle Aged
Female
Risk Factors
Adult
Aged
Cardiometabolic Risk Factors
Fatty Liver epidemiology

Language :: English
ISSN :: 1542-7714
Volume :: 22
Issue :: 11
Database :: MEDLINE
Journal :: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Publication Type :: Academic Journal
Accession number :: 38857746
Full Text :: https://doi.org/10.1016/j.cgh.2024.05.030

Full Text Access

Tools